FanDuel CEO Amy Howe is out after five years at the sportsbook
Howe has overseen FanDuel during a time of dramatic expansion in sports gambling and as prediction markets have exploded in popularity....
Author : Douglas L. Grider
Apollo CEO Rowan warns of market correction, slams ‘egregious’ practices at rival insurers
Apollo CEO Marc Rowan warned that markets face an elevated risk of unexpected shocks, saying he is positioning the firm defensively for an expected correction....
Wearable patches: How Barrière is trying to disrupt the supplement industry
Supplement patch company Barrière is launching the first-ever lactose intolerance patch in 1,700 Walmart stores, the company told CNBC exclusively....
Disney reports earnings before the bell. Here’s what to expect
Disney’s second-quarter earnings report comes less than two months after Josh D’Amaro took the helm as CEO....
AMC to screen live concerts through Arena One partnership
More than 300 AMC locations in 89 markets across the U.S. will be programmed for live concert screenings. Tickets will range from $40 to $75....
Spirit starts monthslong process of dismantling airline after biggest collapse in a generation
Spirit Airlines was back in bankruptcy court to start dismantling the airline....
FDA commissioner defends agency’s drug approval decisions after wave of backlash
U.S. Food and Drug Administration Commissioner Marty Makary, under pressure, defends himself in an interview with CNBC’s David Faber....
Nvidia and Pulte are helping this startup put mini data centers on homes
A network of Span nodes, communicating with each other across the country, is the equivalent of a small to mid-sized traditional data center....
Spirit Airlines CEO on carrier’s collapse: ‘We just kind of ran out of runway’
Spirit Airlines shut down before dawn on Saturday ending its run as the most famous U.S. discount airline....
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance
Early signs from the launch of Novo Nordisk’s Wegovy pill and Eli Lilly & Co.’s Foundayo are making investors rethink the opportunity for GLP-1 pills....